Search results
Exelixis Inc (EXEL) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
GuruFocus.com via Yahoo Finance· 3 days agoCABOMETYX Net Product Revenues: $376.4 million, including about $6 million in clinical trial sales. Gross to Net Deductions: 32.9% for Q1 2024, primarily due to higher Medicare</ ...
Exelixis (EXEL) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 3 days agoThis increase in gross-to-net deductions in the first quarter of 2024 is primarily related to higher Medicare Part D and PHS expenses ...
Collegium (COLL) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 5 days agoBelbuca prescriptions grew 3.2% in the previous quarter and a similar trend is likely to have driven...
Florida Blue Medicare Advantage 2024 Review - NerdWallet
Nerdwallet· 13 hours agoStar ratings are determined by the Centers for Medicare & Medicaid Services (CMS). Florida Blue...
What if I can't find a doctor? Physician shortage will change how Americans receive care.
USA TODAY Opinion via Yahoo News· 3 days agoFDA approval may help burst Big Pharma myths. Making it easier for patients to take their medicines...
United Therapeutics (UTHR) Q1 Earnings Top, Tyvaso Drives Sales
Zacks via Yahoo Finance· 2 days agoSales of Tyvaso DPI were driven by higher volumes and increased commercialization utilization of the...
Pfizer stock gains 7% after earnings beat, company calls dividend 'secure'
Yahoo Finance· 2 days agoEliquis represents nearly 14% of Pfizer’s Q1 revenue, and we recognize the uncertainty tied to the...
GSK raises forecasts on strong vaccine, HIV drug sales
BioPharma Dive via Yahoo Finance· 3 days agoSales of the shingles vaccine Shingrix and the RSV shot Arexvy helped fuel quarterly revenue totals...
Medigap Policies Face New Federal Nondiscrimination Rule | ThinkAdvisor
ThinkAdvisor· 5 days agoThe U.S. Department of Health and Human Services is changing its strategy for regulating Medicare...
Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life
BioPharma Dive via Yahoo Finance· 3 days agoSales of the transthyretin amyloidosis treatment widely beat Wall Street forecasts in the first...